NETSTREIT (NYSE:NTST) Given New $20.00 Price Target at Scotiabank

NETSTREIT (NYSE:NTSTGet Free Report) had its price target dropped by investment analysts at Scotiabank from $22.00 to $20.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s price target points to a potential upside of 8.77% from the company’s previous close.

A number of other analysts also recently issued reports on NTST. Mizuho lowered their target price on NETSTREIT from $23.00 to $20.00 and set an “outperform” rating on the stock in a research report on Thursday, September 17th. UBS Group set a $22.00 price target on shares of NETSTREIT in a research note on Thursday, June 18th. Jefferies Financial Group reiterated a “buy” rating and issued a $25.00 target price on shares of NETSTREIT in a research note on Wednesday, July 29th. Robert W. Baird raised their price objective on NETSTREIT from $22.00 to $23.00 and gave the company an “outperform” rating in a research report on Thursday, July 23rd. Finally, BMO Capital Markets raised their price target on NETSTREIT from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Monday, July 20th. Thirteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.81.

Read Our Latest Stock Report on NETSTREIT

NETSTREIT Price Performance

Shares of NYSE NTST opened at $18.39 on Thursday. The company has a fifty day moving average price of $20.50 and a 200 day moving average price of $20.36. NETSTREIT has a 1-year low of $17.02 and a 1-year high of $22.47. The firm has a market cap of $1.87 billion, a PE ratio of 122.58, a PEG ratio of 2.37 and a beta of 0.80. The company has a current ratio of 3.55, a quick ratio of 3.54 and a debt-to-equity ratio of 0.88.

NETSTREIT (NYSE:NTSTGet Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.02). The firm had revenue of $61.28 million for the quarter, compared to the consensus estimate of $56.41 million. NETSTREIT had a return on equity of 0.95% and a net margin of 6.35%.NETSTREIT has set its FY 2026 guidance at 1.370-1.390 EPS. Research analysts predict that NETSTREIT will post 1.3 earnings per share for the current fiscal year.

Institutional Investors Weigh In On NETSTREIT

A number of large investors have recently bought and sold shares of the company. Bank of America Corp DE bought a new position in shares of NETSTREIT in the 2nd quarter valued at $63,046,000. Public Employees Retirement System of Ohio acquired a new stake in NETSTREIT in the second quarter valued at about $2,339,000. Easterly Investment Partners LLC bought a new position in NETSTREIT in the fourth quarter valued at about $9,422,000. William Blair Investment Management LLC bought a new position in NETSTREIT in the second quarter valued at about $17,695,000. Finally, Dockside LLC acquired a new position in NETSTREIT during the second quarter worth about $1,202,000.

About NETSTREIT

(Get Free Report)

NETSTREIT Corp. is a real estate investment trust (REIT) focused on owning and managing healthcare real estate in the United States. The company primarily invests in outpatient medical office properties that support essential healthcare services, including clinics, physician practices, specialty care facilities and other medical providers.

NETSTREIT generally leases its properties to healthcare systems, physician groups and other medical operators under long-term, net lease arrangements.

Read More

Analyst Recommendations for NETSTREIT (NYSE:NTST)

Receive News & Ratings for NETSTREIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NETSTREIT and related companies with MarketBeat.com's FREE daily email newsletter.